Logo

ATOM

Atomera Incorporated

ATOM

Atomera Incorporated NASDAQ
$2.48 4.20% (+0.10)

Market Cap $78.57 M
52w High $17.55
52w Low $1.89
Dividend Yield 0%
P/E -3.7
Volume 105.99K
Outstanding Shares 31.68M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $11K $5.676M $-5.573M -50.664K% $-0.18 $-5.55M
Q2-2025 $0 $4.867M $-4.967M 0% $-0.16 $-4.623M
Q1-2025 $4K $5.467M $-5.209M -130.225K% $-0.17 $-4.864M
Q4-2024 $23K $4.882M $-4.657M -20.248K% $-0.17 $-4.308M
Q3-2024 $22K $4.819M $-4.595M -20.886K% $-0.17 $-4.493M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $20.322M $21.941M $2.911M $19.03M
Q2-2025 $22.026M $24.084M $2.793M $21.291M
Q1-2025 $24.123M $26.252M $2.969M $23.283M
Q4-2024 $26.773M $29.124M $4.047M $25.077M
Q3-2024 $17.342M $20.14M $4.247M $15.893M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-5.573M $-3.362M $-13K $1.671M $-1.704M $-3.375M
Q2-2025 $-4.967M $-3.505M $-10K $1.418M $-2.097M $-3.515M
Q1-2025 $-5.209M $-4.782M $996K $2.131M $-1.655M $-4.786M
Q4-2024 $-4.657M $-3.028M $2.608M $12.441M $12.021M $-3.036M
Q3-2024 $-4.595M $-2.895M $272K $1.896M $-727K $-2.889M

Five-Year Company Overview

Income Statement

Income Statement Atomera is essentially still a pre‑revenue company. Over the past several years it has not generated meaningful sales, while recording steady losses each year. The size of those losses has been relatively stable, which suggests disciplined cost control, but it also highlights that the business remains firmly in the development and commercialization phase rather than in a mature, revenue‑producing stage. The income statement today looks more like that of a research venture than an operating semiconductor business.


Balance Sheet

Balance Sheet The balance sheet is small and straightforward. Assets are modest and largely made up of cash, with very little in the way of physical plant or equipment. The company has operated with little to no debt in recent years, which reduces financial pressure but also means it must rely mainly on equity and future licensing income for funding. Shareholders’ equity is positive but has been gradually eroded by ongoing losses, a normal pattern for an early‑stage tech firm that has not yet turned the corner to revenue.


Cash Flow

Cash Flow Cash flows show a consistent pattern of money going out to fund operations and none coming in from customers at scale. Operating cash burn has been fairly steady from year to year, indicating predictable spending but also underlining that the business is not self‑funding. Capital spending needs are very low, which fits a licensing and R&D model. In practice, this means the company’s future depends on either raising more capital or converting its pipeline of customer engagements into paying, recurring license and royalty streams.


Competitive Edge

Competitive Edge Atomera’s competitive strength lies in its intellectual property and know‑how rather than size or market share. Its MST technology is protected by a large patent portfolio with long‑dated protection, and it is designed to fit into existing chip manufacturing flows, which lowers switching barriers for fabs. The company has signed licenses and collaborations with recognized semiconductor players, which supports its technical credibility. At the same time, Atomera is tiny compared with large materials and IP providers, and adoption cycles in semiconductors are slow and conservative. The main competitive risk is not a direct rival with the same technology, but the possibility that big customers delay or bypass adoption, or that alternative process improvements win out.


Innovation and R&D

Innovation and R&D Innovation is the core of Atomera’s story. MST and its variants aim to squeeze more performance, efficiency, and reliability out of standard silicon processes, addressing the industry’s need for “more than Moore” improvements without expensive factory overhauls. The company has broadened this platform with tools like MSTcad to help customers model benefits up front, and it is pushing into new areas such as GaN‑on‑silicon for high‑power and RF applications. Partnerships with industrial players, research labs, and participation in national semiconductor initiatives reinforce its position at the R&D frontier. The main uncertainty is not whether the technology is novel, but how widely and quickly it can be adopted in high‑volume production.


Summary

Atomera is an early‑stage semiconductor materials and IP licensing company whose financials reflect a long investment in research and customer development, with no meaningful commercial scale yet. The balance sheet is clean and mostly cash, but limited in size, so continued losses put a premium on successful commercialization or future capital raises. On the strategic side, the company appears to have a meaningful technological edge backed by patents, strong fit with existing fab infrastructure, and a growing network of industry partners. The key questions going forward are execution and timing: can Atomera turn technical wins and pilot projects into broad, recurring license and royalty revenue before its financial resources become too constrained? Outcomes could vary widely depending on how those commercialization milestones play out.